Cell Therapy Manufacturing
Cell Therapy Manufacturing - Related Videos
06:18
Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
0 Views •
Cited by 7 •
2023
This article details the manufacturing process for chimeric antigen receptor T cells for clinical use, specifically using an automated cell processor capable of performing viral transduction and cultivation of T cells. We provide recommendations and describe pitfalls that should be considered during the process development and implementation of an early-phase clinical trial.
07:48
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
0 Views •
Cited by 20 •
2011
A high-throughput, automated platform of manufacturing cell line development for producing protein therapeutics is described. Implementation of BD FACS Aria Cell Sorter, CloneSelect Imager and TECAN Freedom EVO liquid handling system has demonstrated significantly increased processing capacity in cell line development with improved cell line quality and high reproducibility.
04:38
An Ex Vivo Technique to Manufacture Chimeric Antigen Receptor T Cells
0 Views •
2025
This video demonstrates a technique to manufacture chimeric antigen receptor (CAR) T cells ex vivo. Human T cells are incubated with magnetic beads coated with anti-CD3 and anti-CD28 antibodies, along with a medium supplemented with interleukin-2 (IL-2), leading to T cell activation and proliferation. Transgenic lentiviral vectors are introduced, allowing the transgenic RNA to integrate into the host genome and express the transgene. This results in the transduced T cells expressing chimeric...
01:26
Steel Manufacturing
0 Views •
2024
Steel manufacturing is a multi-stage process that begins by smelting iron ore into cast iron in a blast furnace. This initial stage involves layering iron ore with coke, a type of fuel, and crushed limestone within the furnace. The coke is ignited with a high volume of air, leading to the creation of carbon monoxide, which acts to reduce the iron ore to pure iron. During this smelting process, limestone plays a crucial role by forming slag. Slag captures impurities within the molten iron, such...
01:26
Good Manufacturing Practices
0 Views •
2026
Good Manufacturing Practices (GMP) constitute a foundational set of guidelines that ensure the production of safe, consistent, and high-quality products, particularly in industries such as pharmaceuticals, biotechnology, and food processing. These protocols encompass all aspects of production, from the sourcing of raw materials to the final distribution of the finished product.A core pillar of GMP is stringent hygiene and sanitation across all production environments. This includes routine...
FAQs
Activation can prepare immune cells for expanded or enhanced functional activity, while genetic modification can alter cellular properties before production continues. These interventions are selected according to the intended therapeutic strategy, such as improving pathogen recognition or replacing dysfunctional immune populations. Their controlled use helps connect the starting biological material with the desired treatment function.
Defined culture conditions help control how therapeutic cells expand before formulation and administration. Consistent conditions support reproducible production from one manufacturing run to another, which is especially important when biological starting materials vary. In infection and immunology research, this control helps investigators evaluate immune-cell products with greater confidence and supports movement from experimental workflows toward clinical translation.
Identity confirms that the intended cell population was produced, while viability indicates how many cells remain alive. Potency addresses whether the product can perform its intended biological function, and sterility and safety testing address risks associated with administration. Evaluating these attributes together helps determine whether a manufactured product is consistent, functional, and suitable for further development.
Standardized workflows reduce variation across processing steps, including isolation, activation or modification, expansion, formulation, and aseptic handling. Greater consistency makes experimental outcomes easier to compare and helps distinguish biological effects from manufacturing differences. This principle supports reproducible research, more reliable quality testing, and the broader clinical translation of cellular medicines.
A typical workflow begins with a biological starting material and proceeds through cell isolation, followed when needed by activation or genetic modification. The cells are then expanded under defined culture conditions, formulated, and processed aseptically. Quality control evaluates identity, viability, potency, sterility, and safety before the resulting product advances toward administration or further study.
Manufacturing enables researchers to develop immune-cell therapies designed to improve pathogen recognition, replace dysfunctional immune populations, or support targeted treatment strategies. The production process converts these biological objectives into quality-tested cellular products that can be investigated systematically. This connection makes manufacturing a practical bridge between immunological concepts, infection-focused research, and potential clinical use.
Personalized cellular medicines may require production workflows that accommodate an individual patient’s biological starting material, whereas broader access depends on processes that can be scaled consistently. Manufacturing must therefore balance biological specificity with reproducibility and quality control. Achieving that balance can support clinical translation while helping make cellular treatments more practical for wider use.